Benedikt Schrage1,2, Nicole Rübsamen1, Andreas Schulz3, Thomas Münzel4,5, Norbert Pfeiffer6, Philipp S Wild4,7,8, Manfred Beutel9, Irene Schmidtmann10, Rosemarie Lott11, Stefan Blankenberg1,2, Tanja Zeller1,2, Karl J Lackner4,11, Mahir Karakas12,13. 1. Department of General and Interventional Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany. 2. DZHK (German Center for Cardiovascular Research), Partner site, Hamburg/Kiel/Lübeck, Germany. 3. Centre of Medicine II (Statistics), University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany. 4. DZHK (German Center for Cardiovascular Research), Partner Site Rhine-Main, Mainz, Germany. 5. Center for Cardiology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany. 6. Department for Opthalmology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany. 7. Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany. 8. Center for Thrombosis and Hemostasis, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany. 9. Department of Psychosomatic Medicine and Psychotherapy, University Medical Center, Johannes Gutenberg-University Mainz, Mainz, Germany. 10. Institute for Medical Biometry, Epidemiology and Informatics, University Medical Center Mainz, Mainz, Germany. 11. Institute for Clinical Chemistry and Laboratory Medicine, University Medical Center Mainz, Mainz, Germany. 12. Department of General and Interventional Cardiology, University Heart and Vascular Center Hamburg, Hamburg, Germany. m.karakas@uke.de. 13. DZHK (German Center for Cardiovascular Research), Partner site, Hamburg/Kiel/Lübeck, Germany. m.karakas@uke.de.
Abstract
BACKGROUND: Iron deficiency is now accepted as an independent entity beyond anemia. Recently, a new functional definition of iron deficiency was proposed and proved strong efficacy in randomized cardiovascular clinical trials of intravenous iron supplementation. Here, we characterize the impact of iron deficiency on all-cause mortality in the non-anemic general population based on two distinct definitions. METHODS: The Gutenberg Health Study is a population-based, prospective, single-center cohort study. The 5000 individuals between 35 and 74 years underwent baseline and a planned follow-up visit at year 5. Tested definitions of iron deficiency were (1) functional iron deficiency-ferritin levels below 100 µg/l, or ferritin levels between 100 and 299 µg/l and transferrin saturation below 20%, and (2) absolute iron deficiency-ferritin below 30 µg/l. RESULTS: At baseline, a total of 54.5% of participants showed functional iron deficiency at a mean hemoglobin of 14.3 g/dl; while, the rate of absolute iron deficiency was 11.8%, at a mean hemoglobin level of 13.4 g/dl. At year 5, proportion of newly diagnosed subjects was 18.5% and 4.8%, respectively. Rate of all-cause mortality was 7.2% (n = 361); while, median follow-up was 10.1 years. After adjustment for hemoglobin and major cardiovascular risk factors, the hazard ratio with 95% confidence interval of the association of iron deficiency with mortality was 1.3 (1.0-1.6; p = 0.023) for the functional definition, and 1.9 (1.3-2.8; p = 0.002) for absolute iron deficiency. CONCLUSIONS: Iron deficiency is very common in the apparently healthy general population and independently associated with all-cause mortality in the mid to long term.
BACKGROUND:Iron deficiency is now accepted as an independent entity beyond anemia. Recently, a new functional definition of iron deficiency was proposed and proved strong efficacy in randomized cardiovascular clinical trials of intravenous iron supplementation. Here, we characterize the impact of iron deficiency on all-cause mortality in the non-anemic general population based on two distinct definitions. METHODS: The Gutenberg Health Study is a population-based, prospective, single-center cohort study. The 5000 individuals between 35 and 74 years underwent baseline and a planned follow-up visit at year 5. Tested definitions of iron deficiency were (1) functional iron deficiency-ferritin levels below 100 µg/l, or ferritin levels between 100 and 299 µg/l and transferrin saturation below 20%, and (2) absolute iron deficiency-ferritin below 30 µg/l. RESULTS: At baseline, a total of 54.5% of participants showed functional iron deficiency at a mean hemoglobin of 14.3 g/dl; while, the rate of absolute iron deficiency was 11.8%, at a mean hemoglobin level of 13.4 g/dl. At year 5, proportion of newly diagnosed subjects was 18.5% and 4.8%, respectively. Rate of all-cause mortality was 7.2% (n = 361); while, median follow-up was 10.1 years. After adjustment for hemoglobin and major cardiovascular risk factors, the hazard ratio with 95% confidence interval of the association of iron deficiency with mortality was 1.3 (1.0-1.6; p = 0.023) for the functional definition, and 1.9 (1.3-2.8; p = 0.002) for absolute iron deficiency. CONCLUSIONS:Iron deficiency is very common in the apparently healthy general population and independently associated with all-cause mortality in the mid to long term.
Entities:
Keywords:
General population; Iron deficiency; Risk factor
Authors: Elio Venturini; Gabriella Iannuzzo; Anna DI Lorenzo; Gianluigi Cuomo; Andrea D'Angelo; Pasquale Merone; Giuseppe Cudemo; Mario Pacileo; Antonello D'Andrea; Carlo Vigorito; Francesco Giallauria Journal: Int J Cardiol Heart Vasc Date: 2022-05-02
Authors: Susanne Macher; Cornelia Herster; Magdalena Holter; Martina Moritz; Eva Maria Matzhold; Tatjana Stojakovic; Thomas R Pieber; Peter Schlenke; Camilla Drexler; Karin Amrein Journal: Nutrients Date: 2020-05-05 Impact factor: 5.717
Authors: Benedikt Schrage; Nicole Rübsamen; Francisco M Ojeda; Barbara Thorand; Annette Peters; Wolfgang Koenig; Stefan Söderberg; Maja Söderberg; Ellisiv B Mathiesen; Inger Njølstad; Frank Kee; Allan Linneberg; Kari Kuulasmaa; Palosaari Tarja; Veikko Salomaa; Stefan Blankenberg; Tanja Zeller; Mahir Karakas Journal: ESC Heart Fail Date: 2021-10-05